Menopausal Hormone Therapy (HRT) and Breast Cancer Risk has been in the news. Find out what you may need to clarify with your health care provider.
MHT and Breast Cancer Risk – Lancet
What is the name of the paper about MHT and Breast Cancer Risk published in The Lancet on 29 August 2019?
In this paper, what was the Interpretation?
If these associations are largely causal, then for women of average weight in developed countries, 5 years of MHT, starting at age 50 years, would increase breast cancer incidence at ages 50–69 years by about one in every 50 users of oestrogen plus daily progestagen preparations; one in every 70 users of oestrogen plus intermittent progestagen preparations; and one in every 200 users of oestrogen-only preparations. The corresponding excesses from 10 years of MHT would be about twice as great”.
What did the International Menopause Society’s (IMS) response to this paper include?
On page one in The International Menopause Society Comment on: “Type and Timing of Menopausal Hormone Therapy and Breast Cancer Risk: Individual Participant Meta-Analysis of the Worldwide Epidemiological Experience” the IMS elaborate on:
- Much of the information regarding breast cancer risk and MHT reported in this paper is not new…
- It is important to note that, because of when the data included in this report was collected, most of the MHT regimes were different from those used today
- This paper provides an important public health message about obesity and breast cancer risk…”.
What did the Australasian Menopause Society (AMS) (Australia and New Zealand) response to this paper include?
What did the British Menopause Society’s (BMS) response to this paper include?
What is HRT?
HRT can be an abbreviation for Hormone Replacement Therapy.
Health Care Provider
In response to this paper, what are Recommendations from the IMS?
On page two in The International Menopause Society Comment on: “Type and Timing of Menopausal Hormone Therapy and Breast Cancer Risk: Individual Participant Meta-Analysis of the Worldwide Epidemiological Experience” the IMS state:
Women enter menopause across a range of ages, with diverse symptoms and health risk profiles. The International Menopause Society advocates the comprehensive assessment of women, including attention to modifying risk factors for chronic disease such as being overweight or obese, the importance of which have been highlighted in this Lancet paper. The benefits and risks of MHT differ according to the timing of menopause such that individualisation of therapy is essential. As prescribing practices have changed significantly over the last decade, further research is needed to determine the impact of currently recommended regimens”.
In Menopause Experts Dismiss Some Breast Cancer Claims In New Report the JH elaborate on:
Health Topics A-Z
Where may I find Health Topics related to MHT and Breast Cancer Risk?
In Health Topics A-Z you may find:
- Breast Cancer
- Breast Cancer Screening
- Hormone Therapy
- Hormone Therapy 2016 Revised Global Consensus Statement
- Hormone Therapy and Breast Cancer
- Hormone Therapy and Estrogen Plus Progestogen Therapy
- Hormone Therapy and Estrogen Therapy
- Hormone Therapy Alternatives
- Hormone Therapy Benefits and Risks
- Women’s Health Initiative
Where may I find Links related to MHT and Breast Cancer Risk?
Your Country may have Links similar to: